Skip to content

Prenatal Alcohol Biomarker Study in Uruguay

Newborn Phosphatidylethanol Screening to Detect Fetal Alcohol Exposure in Uruguay

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02600624
Enrollment
1412
Registered
2015-11-09
Start date
2016-08-18
Completion date
2019-07-31
Last updated
2020-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Alcohol Syndrome

Brief summary

The purpose of this study is to examine the association between maternal alcohol use and newborn phosphatidylethanol (PEth) levels in their newborn.

Detailed description

The goal of the proposed research study is to examine the association between maternal alcohol use and newborn phosphatidylethanol (PEth) levels in their newborn children, in a country (Uruguay) where significant alcohol use is common during pregnancy. Maternal alcohol biomarker assays will include ethyl glucuronide (EtG) in hair and nails and PEth in blood obtained at the time of delivery. Newborn umbilical cord and routine 48 hour heel stick blood will be collected to assess newborn PEth levels. Maternal biomarker levels will be compared to patient self-reported alcohol use. This proposed design is a cross-sectional study that will include 1,800 women 18 years and older and their newborns. Women who are admitted to one of two selected public health care hospitals in Montevideo, Uruguay (Hospital Pereira Rossell and Servicio Medico Integral) for obstetrical care will be recruited to participate in the study. Power estimates suggest that 1,800 maternal/infant pairs will give us sufficient power (\>90%) to estimate the predictive validity of this biomarker as a routine newborn screening test.

Interventions

None listed

Sponsors

Northwestern University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inclusion criteria for experimental group (n=1,800) * Pregnant women 18 years and older * Admitted in active labor as well as their newborn child * Well enough to participate in the research interview * Able to provide fingernail, hair, and blood spot samples * All subjects must have given signed, informed consent prior to registration

Exclusion criteria

* Not meeting the appropriate inclusion criteria or providing consent

Design outcomes

Primary

MeasureTime frameDescription
Newborn Phosphatidylethanol Screening to Detect Fetal Alcohol Exposure in UruguayThe maternal questionnaire will occur during the 48 hrs following childbirthConduct a formative assessment of the prevalence and patterns of maternal alcohol consumption during pregnancy and the relationship of these reported patterns to maternal biomarker levels (EtG in hair and nails and PEth in blood) in a large sample (n=1800) of pregnant women in Montevideo, Uruguay.

Secondary

MeasureTime frameDescription
Newborn Phosphatidylethanol Screening to Detect Fetal Alcohol Exposure in UruguayPEth and EtG Biomarkers from the mothers and newborns will be collected during the 48 hrs after childbirth.Biomarkers will be collected to determine the correlations between maternal self-report of alcohol consumption, maternal alcohol biomarker levels and newborn PEth concentration levels at birth. It will also help identify the sensitivity and specificity of PEth and the predictive value of newborn PEth levels; and the half-life and window of detection of PEth in newborns by examining the kinetics of PEth elimination.

Countries

United States, Uruguay

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026